Q1 musings12 Mar 2020 12:23
What a hoot as we near the end of quarter 1, a quick review of hopes and expectations from Q4 2019 and what team ramp would have you believe :
No debt - see this old chestnut is still coming out even though GR in last webinar categorically told you the company does have debt
Plant arriving to dig holes and generate revenue - mmmm, well no announcement means no arrival. A whole 19 hour journey and a few permits but still SFA. Anybody else getting the feeling we have another KME abortion on the horizon?
Tailings off to processing - despite Napom's erstwhile opinion that 2 weeks was reasonable to get results we're well past that now. Presume we ain't actually got the dosh to get the work done.
Nieff meeting 11th Mar - guess sfa occurred there either as the crass excuses about how long it takes for an RNS to come out have started
EPO - ha ha ha ha ha
So a qtr of nothing, nada, zilch, sfa etc, well except for one thing the top of the pyramid have continued to take their obscene renumeration and we're 3 months into the MNH agreement, what must we have now run up for these over the quarter £150-£250K is my estimation. Going to need a 20% dilution just to cover all this crap before we can consider money for moving forward.
And just to add the joy only another few weeks and the Regent loan is up for renewal ..... by gum the effect of compounding interest will be taking its toll there.
Probably explains why you can buy for just over 0.0007 and get just over 0.00065 to sell, pretty much odd's on we'll be revisiting the lows of last year as it's going to need the mother of all dilutions to get this back on track.
Pays your money and takes your chances ...... just going to sit and watch, bigger problems than just needing patience with this one IMO but each to their own. Why bother now when it'll be 0.0004-0.0002 if the Q1 momentum continues (yes that's taking the P).
Roll on EGM, should have done it months ago when it was 0.00175 because it's going to hurt like hell in the current environment.